Physician profile
Jade A Malcolm
NPI 1568734804
$766.19
in general payments reported to CMS, 2019-2025
14 companies · $337 in 2025
The $337 reported for 2025 was more than what 77% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.80 · 2023: $148 · 2024: $197 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $149.34 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $127.94 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $83.07 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $61.22 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $60.13 | 2023-2024 | |
| Exeltis, USA INC. | $58.17 | 2023-2025 | Slynd |
| Organon LLC | $52.17 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $47.30 | 2024 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Daiichi Sankyo INC. | $33.81 | 2022-2023 | Injectafer |
| Abbvie INC. | $33.04 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $15.95 | 2025 | |
| Teleflex LLC | $15.89 | 2025 | Quikclot |
| Medtronic, INC. | $14.47 | 2025 | Venaseal |
| Pfizer INC. | $13.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Malcolm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.